Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.71
+0.34006.33%
Pre-market: 5.62-0.0900-1.58%07:16 EST
Volume:1.19M
Turnover:6.68M
Market Cap:794.40M
PE:-1.58
High:5.74
Open:5.35
Low:5.33
Close:5.37
52wk High:14.45
52wk Low:4.16
Shares:139.13M
Float Shares:94.55M
Volume Ratio:0.79
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6228
EPS(LYR):-3.8310
ROE:-49.06%
ROA:-25.97%
PB:1.00
PE(LYR):-1.49

Loading ...

Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2025

Major Issues Report

Form 8-K - Current report
Jul 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]